MENU
LYRA
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Lyra Therapeutics (LYRA) Ownership - Who owns Lyra Therapeutics?

Lyra Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of anti-inflammatory therapies for the localized treatment of patients with chronic rhinosinusitis, or CRS... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.33M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
31.38M
Revenue
600K
Risk (Beta)
3.08
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.26 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases

Industry Biotechnology

Profile
Details